CLPT Stock Analysis: Buy, Sell, or Hold?
CLPT - ClearPoint Neuro, Inc. Common Stock
$8.66
-0.41 (-4.52%)
▼
5d:
-8.94%
30d:
-31.11%
90d:
-38.23%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
CLPT is down 15.3% this week, but smart money is accumulating calls. Top strike: $12.5 2026-05-15 with 439 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When CLPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLPT is currently trading at $8.66, which is considered oversold relative to its 30-day fair value range of $8.95 to $13.14.
Technical Outlook: Technically, CLPT is in a downtrend. The price is currently testing key support at $8.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CLPT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+188.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLPT is in a downtrend. The price is currently testing key support at $8.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CLPT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+188.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$8.95 -
$13.14
Company Quality Score
44/100
(HOLD)
Options IV Signal
70th percentile
(ELEVATED)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding CLPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 70th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 188.7% below Wall St target ($25.00)
- CAUTION: 5-day price weakness (-8.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$8.95 -
$13.14
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.52
(17.6%)
Support & Resistance Levels
Support Level
$8.63
Resistance Level
$11.34
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.63
Wall Street Target
$25.00
(+188.7%)
Revenue Growth (YoY)
34.0%
Profit Margin
-69.1%
Share & Embed Analysis
Last updated: March 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Burnett
SELL
2943 shares
2026-01-26
Joseph Burnett
SELL
20000 shares
2026-01-09
Joseph Burnett
SELL
26463 shares
2025-10-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
Advanced CLPT Option Strategies
Professional options setups generated by AI based on today's CLPT price and gamma walls.
